Bioceres Crop Solutions (NASDAQ:BIOX) Announces Earnings Results

Bioceres Crop Solutions (NASDAQ:BIOX) issued its quarterly earnings results on Monday. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11), Zacks reports. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period in the previous year, the company earned ($0.07) EPS.

Bioceres Crop Solutions Price Performance

Shares of BIOX stock opened at $6.84 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.86 and a current ratio of 1.24. Bioceres Crop Solutions has a fifty-two week low of $5.71 and a fifty-two week high of $14.05. The firm has a market cap of $429.89 million, a P/E ratio of 360.68 and a beta of 0.49. The business’s 50 day moving average price is $7.73 and its 200-day moving average price is $9.85.

Wall Street Analyst Weigh In

A number of research firms recently commented on BIOX. Oppenheimer reduced their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Roth Mkm reduced their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Canaccord Genuity Group decreased their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday. Lake Street Capital cut their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Finally, Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $12.13.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.